Clinical Trial Update: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder [Phase 3]

View source ↗

Summary

This clinical trial update reports the results of a Phase 3 study of cannabidiol oral solution as an adjunctive treatment for treatment-resistant seizures. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Cannabidiol Oral Solution (cannabidiol)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Seizures | Phase 3 | Status: COMPLETED | Results posted: 2018-07-26